PharmaSGP Holding SE (FRA:PSG)
Germany flag Germany · Delayed Price · Currency is EUR
23.60
0.00 (0.00%)
Last updated: Apr 25, 2025

PharmaSGP Holding SE Company Description

PharmaSGP Holding SE manufactures and sells over-the-counter drugs and other healthcare products in Germany.

The company’s pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage creams for the treatment of various pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Revitensin, a drug for the treatment of hair loss; Dorisol for neuralgia (nerve pain), headaches, and migraines; Fulminan, a beauty drink; Lindaven, a pharmaceutical drops to treat their unpleasant problem; and SCLEROCALMAN, a drug for the treatment of clogged cerebral blood vessels.

It also offers Prostacalman, a medication for cystitis and urination discomfort in a benign enlarged prostate; Revoten for women with weak connective tissue; Mindalin, a micronutrient drink for a healthy cardiovascular system; MELISTON, a prescription-free tablets to treat anxiety, restlessness, and mood swings; Deruba, a cream for skin redness; Lentisol that prevents the formation of new pigment spots; Neodolor, a headache tablet; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo.

The company sells its products through pharmacies and wholesalers. It also exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France.

The company was founded in 2012 and is based in Gräfelfing, Germany.

PharmaSGP Holding SE
Country Germany
Founded 2012
Industry Pharmaceutical Preparations
Employees 89
CEO Peter Gerckens

Contact Details

Address:
Lochhamer Schlag 1
Gräfelfing, 82166
Germany
Phone 49 89 85 89 639
Website pharmasgp.com

Stock Details

Ticker Symbol PSG
Exchange Frankfurt Stock Exchange
Fiscal Year January - December
Reporting Currency EUR
SIC Code 2834

Key Executives

Name Position
Peter Gerckens Chief Executive Officer
Michael Rudolf Chief Financial Officer